Lexicon Pharmaceuticals | Pasivo Circulante

Current Liabilities Cambio Fecha
Abbott USD 14.35B 180M 2023-06
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Akebia Therapeutics USD 99.87M 20.17M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Illumina USD 1.57B 88M 2023-12
Insmed USD 225.63M 28.9M 2023-12
Ironwood Pharmaceuticals USD 276.1M 4.48M 2023-12
J&J USD 44.37B 9.8B 2023-09
MannKind USD 104.12M 7.75M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
PTC Therapeutics USD 603.1M 110.98M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Thermo Fisher Scientific USD 14.01B 146M 2023-12
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
United Therapeutics USD 804.4M 60.3M 2023-12
Vanda Pharmaceuticals USD 87.4M 6.4M 2023-06



Lexicon Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.